| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 05/09/2002 | US20020055513 7-oxo-pyridopyrimidines (II) |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055505 Sultam and sultone derived oxazolidinones |
| 05/09/2002 | US20020055492 Recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. |
| 05/09/2002 | US20020055488 Prevention and treatment of streptococcal and staphylococcal infection |
| 05/09/2002 | US20020055483 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 05/09/2002 | US20020055477 Immunomodulatory formulations and methods for use thereof |
| 05/09/2002 | US20020055473 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 05/09/2002 | US20020055471 Purification step using a brominated polystyrene resin to adsorb anthocyanins |
| 05/09/2002 | US20020055464 Polyacid glycopeptide derivatives |
| 05/09/2002 | US20020055189 Propagating microorganism; mix nutrient broth, inoculate with cells, infect with preferential viruss, recover viral particles |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 05/09/2002 | US20020054921 The extract form the plant genus Phyllanthus belongs to the subfamily of Phyllantoideae which belong to the family of Euphoribiaceae, contacted to the viruses belonging to the family of Flaviviridae |
| 05/09/2002 | US20020054899 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/09/2002 | US20020054888 Dissociated pili, their production and use |
| 05/09/2002 | US20020054887 Toxin has at least one amino acid change and is substantially non-lethal compared with wild type SPE-A toxin; for vaccines |
| 05/09/2002 | US20020054882 Anti-human influenza virus antibody |
| 05/09/2002 | US20020054881 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 05/09/2002 | US20020054868 Bacterial strain, processes plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/09/2002 | US20020054867 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 05/09/2002 | US20020054866 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203817A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 05/08/2002 | EP1203813A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203812A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203775A2 Lymphocyte chemoattractant factor and uses thereof |
| 05/08/2002 | EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases |
| 05/08/2002 | EP1203531A2 Water soluble compositions containing chlorhexidine and their use |
| 05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
| 05/08/2002 | EP1203076A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 05/08/2002 | EP1203072A2 Personal care articles |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1203002A1 Process for preparing a charcoal-gm1 complex |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202987A2 Quinoline derivatives and their use as antibacterial agents |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/08/2002 | EP1202962A1 Pyrrolidine compounds and their use for treating hyperproliferative diseases and tumor diseases |
| 05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 05/08/2002 | EP1202957A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/08/2002 | EP1202954A1 Novel aminobenzophenones |
| 05/08/2002 | EP1202749A2 Enzyme catalyzed anti-infective therapeutic agents |
| 05/08/2002 | EP1202748A2 Polycation-based bioconjugates |
| 05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 05/08/2002 | EP1202741A1 Neurotropic virus transport |
| 05/08/2002 | EP1202737A2 Antiviral therapy use of p-glycoprotein modulators |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202731A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202723A2 Use of anti-muscarinic agents for treating skin disorders |
| 05/08/2002 | EP1202630A1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP0923585B1 Phosphinate based inhibitors of matrix metalloproteases |
| 05/08/2002 | EP0748316B1 Pyrimidine acyclonucleoside derivatives |
| 05/08/2002 | EP0723545B1 Quinolizinone type compounds |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | EP0629240B1 Altered antibodies, products and processes relating thereto |
| 05/08/2002 | EP0625053B1 Urease-based vaccine against helicobacter infection |
| 05/08/2002 | DE10055697A1 Inhibiting onset of AIDS in HIV-positive patients, by adding oligomeric carbohydrates, identical with oligosaccharide haptens on the surface of T-lymphocytes, to serum |
| 05/08/2002 | CN1348500A Novel method for preparing synthesis intermediates |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348492A Pseudomycin production by i(pseudomonas syringae) |
| 05/08/2002 | CN1348490A Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/08/2002 | CN1348466A Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/08/2002 | CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 05/08/2002 | CN1348382A Methods for administration of antibiotics |
| 05/08/2002 | CN1348377A Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/08/2002 | CN1348374A Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4-metabolic pathway, and inhibitors of lipid metabolism |
| 05/08/2002 | CN1348373A Use of 17-ketosteroids for the treatment of malaria and Trypanosomiasis |
| 05/08/2002 | CN1348367A Percutaneous absorption preparations containing oxybutynin |
| 05/08/2002 | CN1348363A Novel pharmaceutical salt form |
| 05/08/2002 | CN1347884A Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 05/08/2002 | CN1347883A Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 05/08/2002 | CN1347882A Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 05/08/2002 | CN1347721A Beriberi eliminating lotion |
| 05/08/2002 | CN1347718A Chinese medicine for treating women's genital system diseases |
| 05/08/2002 | CN1347706A Cold and trachitis treating medicine decoction |
| 05/08/2002 | CN1347695A Nucleotide analogue composition |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/08/2002 | CN1084191C Basin bath medicated liquor for curing tinea pedis, sweaty feet and smelly feet |
| 05/07/2002 | US6384259 Heat resistant, sterile dosage suitable for reconstitution with a vehicle into an injectible, particle-free product for parenteral administration |
| 05/07/2002 | US6384230 2,6-dimethyl-5-((4-ethoxyphenyl)-methoxy)-7-(2-methylthiazol-4-yl)hepta -2,6-dienoic acid ethyl ester from malic acid, wittig reaction with 2-methyl-4-thiazolylmethyl triphenyl phosphonium bromide; intermediates for epothilone a or b |
| 05/07/2002 | US6384213 Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| 05/07/2002 | US6384202 Cell-specific active compounds regulated by the cell cycle |
| 05/07/2002 | US6384198 Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen |
| 05/07/2002 | US6384188 Lipopolysaccharide-binding and neutralizing peptides |
| 05/07/2002 | US6384186 Cyclic dodecapeptide and process for the preparation thereof |